Recombinant Human CD15 Protein，His

CD15, also known as Lewis X, is a carbohydrate antigen expressed on the surface of human cells, particularly prominent in granulocytes and some tissues of the immune system. It plays a crucial role in various biological processes, including cell adhesion, migration, and immune response modulation. Research on CD15 has gained significant attention due to its involvement in inflammatory responses and its potential role in cancer biology, where it may affect tumor cell behavior and metastasis. The presentation of CD15 on leukocytes has made it a valuable marker in the diagnosis and monitoring of certain hematological malignancies, including acute myeloid leukemia and chronic lymphocytic leukemia. The development of recombinant CD15 proteins has opened new avenues for understanding its functional mechanisms and interactions in vitro and in vivo, paving the way for therapeutic applications. By generating specific antibodies against CD15, researchers hope to harness the protein’s properties for targeted therapies, immunotherapeutics, and diagnostic tools. Investigating the structure-function relationship of recombinant CD15 proteins will also enhance our understanding of its role in immune evasion and establish a foundation for innovative strategies in the treatment of cancer and inflammatory diseases. Overall, the study of CD15 and its recombinant forms holds promise for advancing our knowledge of immunology and oncology, potentially leading to improved clinical outcomes for patients.